Mitozolomide
Mitozolomide (M & B 39565) is a prodrug of alkyldiazonium reactive intermediates. Mitozolomide can be converted in vivo to triazenes.
For research use only. We do not sell to patients.
- CAS No.: 85622-95-3
- Formula: C7H7ClN6O2
- Molecular Weight:242.62
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Fibroblast | IC50 |
20 μM
Compound: Mitozolomide
|
In vitro cytotoxicity against human xeroderma pigmentosum fibroblast cells HMGZip (mer-)
In vitro cytotoxicity against human xeroderma pigmentosum fibroblast cells HMGZip (mer-)
|
[PMID: 12459014] |
| Fibroblast | IC50 |
30 μM
Compound: Mitozolomide
|
In vitro cytotoxicity against human xeroderma pigmentosum fibroblast cells HMGZAT (mer+)
In vitro cytotoxicity against human xeroderma pigmentosum fibroblast cells HMGZAT (mer+)
|
[PMID: 12459014] |
| GM892A cell line | IC50 |
4.8 μM
Compound: 2
|
In vitro cytotoxicity against human lymphoblastoid cell line (GM892 A)
In vitro cytotoxicity against human lymphoblastoid cell line (GM892 A)
|
[PMID: 7739008] |
| HCT-116 | IC50 |
17.9 μM
Compound: MTZ
|
Chemosensitization of p53-deficient human HCT116 cells after 5 days by MTT assay
Chemosensitization of p53-deficient human HCT116 cells after 5 days by MTT assay
|
[PMID: 23895620] |
| HCT-116 | IC50 |
60 μM
Compound: MTZ
|
Chemosensitization of human HCT116 cells expressing p53 after 5 days by MTT assay
Chemosensitization of human HCT116 cells expressing p53 after 5 days by MTT assay
|
[PMID: 23895620] |
| Raji | IC50 |
39 μM
Compound: 2
|
In vitro cytotoxicity against Raji cell line
In vitro cytotoxicity against Raji cell line
|
[PMID: 7739008] |
| SNB-19 | GI50 |
10 μM
Compound: 2; MTZ
|
Growth inhibition of empty vector transfected human SNB19 cells after 7 days by MTT assay
Growth inhibition of empty vector transfected human SNB19 cells after 7 days by MTT assay
|
10.1039/C6MD00384B |
| SNB-19 | GI50 |
68.4 μM
Compound: 2; MTZ
|
Growth inhibition of MGMT-transfected human SNB19 cells after 7 days by MTT assay
Growth inhibition of MGMT-transfected human SNB19 cells after 7 days by MTT assay
|
10.1039/C6MD00384B |
| TLX-5 | IC50 |
2.5 μM
Compound: 2
|
In vitro cytotoxicity against mouse TLX5 lymphoma cells
In vitro cytotoxicity against mouse TLX5 lymphoma cells
|
[PMID: 7739008] |
| U-373MG ATCC | GI50 |
22 μM
Compound: 2; MTZ
|
Growth inhibition of empty vector transfected human U373 cells after 7 days by MTT assay
Growth inhibition of empty vector transfected human U373 cells after 7 days by MTT assay
|
10.1039/C6MD00384B |
| U-373MG ATCC | GI50 |
40.3 μM
Compound: 2; MTZ
|
Growth inhibition of MGMT-transfected human U373 cells after 7 days by MTT assay
Growth inhibition of MGMT-transfected human U373 cells after 7 days by MTT assay
|
10.1039/C6MD00384B |
Chemical Information
-
CAS No. 85622-95-3
-
Appearance Solid
-
Molecular Weight 242.62
-
Formula C7H7ClN6O2
-
Color Light brown to brown
-
SMILES
O=C(C(N=CN12)=C2N=NN(CCCl)C1=O)N
-
Synonyms
M & B 39565; CCRG 81010; NSC 353451
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)